- Added to Email Alerts
Chronic Leukemia
Latest News View All
-
ACMS 2024Immunosuppression Risk Factor for Poor cSCC Outcomes -
AlertFDA Approves First CAR T-Cell Therapy for rrCLL, rrSLL -
AlertZanubrutinib Label Expands to Include RR Follicular Lymphoma
-
ASH 2023Measurable Residual Disease-Guided Therapy Promising in CLL -
AlertFDA Approves Pirtobrutinib for Previously Treated CLL/SLL -
'Promising' New Txs for Most Common Adult Leukemia -
BTKi Combo Strong Option in CLL
-
Promising Early Data: Pirtobrutinib in Hard-to-Treat CLL/SLL
Perspective View All
Journal Articles View All
-
Isolated Ocular Mpox Without Skin Lesions, United States
-
Risks of Second Non-Breast Primaries Following Breast Cancer
-
Ibrutinib Plus Venetoclax for First-Line Treatment of CLL
-
Safety of IV Golimumab in RA, PsA, and AS
-
Cryotherapy for Cutaneous Kaposi Sarcoma With B-Cell CLL
-
SARS-CoV-2 Variants in Patient Given Antibody Monotherapy
Additional Resources
Medscape Drugs & Diseases
- Chronic Lymphocytic Leukemia Treatment Protocols
- Chronic Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
- Hairy Cell Leukemia
- Leukemias
Medscape Education